The “newer” progestogens and postmenopausal hormone therapy (HRT)
Adolf E. Schindler
文献索引:J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014)
全文:HTML全文
摘要
• The “newer” progestogens have a high bioavailability. • The “newer” progestogens have a sufficient progestogenic effect. • The “newer” progestogens do not cause undue side effects. • The “newer” progestogens do not jeopardize lipid- and carbohydrate metabolism.
相关化合物
相关文献:
2011-12-01
[J. Sci. Ind. Res. 65(10) , 808, (2006)]
2008-04-10
[J. Med. Chem. 51 , 2047-56, (2008)]
2015-01-01
[J. AOAC Int. 98 , 580-7, (2015)]
2008-10-09
[J. Med. Chem. 51 , 5932-42, (2008)]
2008-06-12
[J. Med. Chem. 51 , 3275-87, (2008)]